Breast Cancer Research to Spearhead Bulk of Histology Embedding Systems Market Expansion

Heightened mortality rates due to improper diagnosis is accelerating R&D efforts to promote advanced diagnostics

Fact.MR, Rockville MD: The global histology embedding systems market is expected to post substantial gains through 2021, as the need to ascertain disease geneses and ultimately timely disbursement of treatment acquire precedence. This trend has become especially overt in the aftermath of the COVID-19 pandemic. Long-term gains appear equally lucrative, exhibiting robust growth until 2031.

As per this study, histology embedding systems are expected to undergo a major transition, underpinned by rapid digitalization of diagnostic approaches. For instance, in August 2020, UK’s National Health Service (NHS) received a £ 50 million funding from the Department of Health and Social Care to establish three digital pathology and imaging AI centers in Coventry, Leeds and London respectively.

Furthermore, scope is expected to be immense across the cancer diagnostics segment. The American Institute for Cancer Research estimates that lung and breast cancers constituted the bulk of global cancer prevalence in 2018, each contributing 12.3% of the total share, surpassing 4 million cases. Hence, players such as Thermo Fisher are offering advanced solutions, such as the OncomineTM Breast cfDNA Assay, comprising of a complex pool of multiplex PCR primers.

“As demand for precision diagnostics aggrandizes, manufacturers are effectively leveraging technological breakthroughs to introduce highly advanced histology embedding systems, widening revenue pools,” says the Fact.MR analyst.  

For more insights into the Market, Request a Sample of this Report

Key Takeaways from Fact.MR’s Histology Embedding Systems Study

  • By application, histopathology to remain a dominant area, attributed to growing demand for advanced disease diagnostics
  • Demand for 7 liter histology embedding systems by paraffin capacity is likely to remain dominant
  • Histopathological labs to emerge as one of the most prominent histology embedding systems utilizers
  • By modularity, the 3 module histology embedding systems are likely to acquire high traction
  • Heavy deployment anticipated across the US, amid accelerating cancer research
  • UK to provide renewed growth opportunities, driven by extensive pathology consolidation initiatives to reduce costs
  • Deepening penetration of digital diagnostics to fuel sales across Germany and France
  • High chronic disease burden to facilitate advanced diagnostics across India & China, strengthening histology embedding system deployment

Histology Embedding System Market- Prominent Drivers

  • Emergence of unidentified and unrecognized chronic and infectious diseases to accelerate histology embedding systems adoption
  • Advancements of diagnostic capabilities through digitization is elevating adoption of histology embedding systems
  • Clinicians are discovering heightened opportunities across molecular profiling for further effective cancer diagnostics

Histology Embedding System Market- Key Restraints

  • High investment costs is likely to restrict adoption to premium hospitals, clinics and diagnostic centers
  • Dearth of skilled pathologists across key geographies to operate advanced embedding systems is expected to restrain growth

Discover more about the histology embedding system market with figures and data tables, along with the table of contents. You will also find detailed market segmentation on

Competitive Landscape

IHC WORLD LLC., Danaher, Electron Microscopy Sciences, KALSTEIN, SM Scientific Instruments Pvt. Ltd., MEDITE GmbH, Thermo Fisher, Ted Pella Inc., Sakura Finetek, VirtualExpo Group, WWR International LLC., and Rushabh Instruments LLC are some prominent histology embedding system manufacturers profiled by Fact.MR in its ongoing study.

Offering state-of-the-art and highly advanced devices constitutes part and parcel of some of the aforementioned players’ expansion prospects. For instance, Electron Microscopy Sciences offers the Tissue-Tek® TECTM Tissue Embedding Console System which provides a compact, single workstation enabling both specimen orientation and paraffin embedding. It comes in a left-to-right or right-to-left configuration.

Likewise, Sakura Finetek offers the Tissue-Tek AutoTEC® a120 automated tissue embedding system, which is the industry’s first fully automatic tissue embedding system which eliminates manual orientation of embedding tissue specimens. The platform utilizes the Tissue-Tek® Paraform® Sectionable Cassette System which ensures that the orientation of specimens is locked from grossing to microtomy, thereby eliminating the risk of orientation mistakes.

More Insights on the Histology Embedding System Market

The research study on the histology embedding system treatment market by Fact.MR includes an in-depth analysis of major demand-driving factors and trends and a comprehensive evaluation of crucial aspects that are projected to carve the growth of the histology embedding system market. Market statistics have been elucidated based on paraffin chamber capacity (2L-3L, 4L-5L, 5L, 6L and 7L), application (histology, histopathology, plant tissue culture, molecular profiling, diagnostics, cancer research and immunohistochemistry), modularity (single module system, 2 module system and 3 module system) and end-users (hospitals, specialty clinics, cancer research labs, pathological labs, histopathological labs and plant tissue cultures) across six major regions (North America, Latin America, Europe, East Asia, South Asia and Middle East & Africa).

Request Methodology & Get a Glimpse of Our Expertise

Explore Fact.MR’s Coverage on the Healthcare Domain

Peak Flow Meter Market: Fact.MR’s market study on the global market for peak flow meter provides detailed assessment on the key market dynamics, including the drivers, trends, opportunities restraints, and detailed information about the peak flow meter market structure. Information about prominent segments and their scope across key geographies has also been presented in the report.

Intraoperative MRI Equipment Market: In the traditional medical landscape, image-guided procedures exhibited pre-operative conditions limitations have required surgeons and physicians to invest in MRI technology. Fact.MR’s offering delivers an insightful forecast on the global market for intraoperative MRI equipment. Periodical developments in the global intraoperative MRI equipment market have been addressed to generate insights on how the demand for these systems will evolve in the near future.

Actigraphy Sensors PSG Devices Market: Fact.MR’s actigraphy sensors PSG devices market report provides an in-depth analysis about the prominent drivers expected to shape future growth trajectory for the upcoming decade. The market report provides detailed explanation on how the actigraphy sensor and PSG devices market will grow, with the help of industry-validated market dynamics that verify the claims made in the report by analysts at Fact.MR.    

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.    

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Follow Us: LinkedIn | Twitter
Market Intelligence Services:
Source: Fact.MR

Back to news